The findings that SAHA/DS induced a stronger cell cycle arrest and apoptosis in pancreatic cancer cells, further enhanced by 5-AZA supplementation, strengthen the hypothesis that targeting multiple epigenetic pathways could be promising against tumors harboring p53 mutations. The gene discussed is TP53; the disease is familial pancreatic carcinoma.